Penumbra Inc (PEN)
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Address
ONE PENUMBRA PLACE
ALAMEDA, CA 94502
Founded
2004
Number of Employees
4,200
Website
http://www.penumbrainc.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s) |
- | - | - | $7,049 | $12,537 | $10,974 | - | - | - | - | - | $10,187 |
| Average Price | - | - | - | $85.46 | $117.40 | $137.10 | - | - | - | - | - | $113.47 |
| # Shares Purchased | - | - | - | 82,492 | 106,792 | 80,044 | - | - | - | - | - | 89,776 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | 117.7% | 58.4% | 35.7% | - | - | - | - | - | 63.9% |
| S&P 500 Return to Date | - | - | - | 129.7% | 104.9% | 93.1% | - | - | - | - | - | 109.2% |
| Excess Total Return | - | - | - | -12.1% | -46.4% | -57.4% | - | - | - | - | - | -45.3% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | 73% | 61% | 53% | - | - | - | - | - | 76% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at PEN make a trade.
Creating a free account takes less than one minute